HOME ABOUT US PRINT PUBLICATIONS SUBSCRIPTIONS CONTACT US RSS
 
Subscriber Sign In
 
Today@FDA
FDA Calendar
 
Archived Daily Updates
 
FDA Whistleblower
 
What do you think?
Search our 63,616-story database
Search
Renew subscription










E-mail This to a Friend | Print Format  
     
 
Draft Guide on 510(k) Third-Party Review Program
09/14/2018
 

Federal Register notice: FDA has made available a draft guidance entitled “510(k) Third-Party Review Program.” The document reflects amendments made to the third-party review program by the FDA Reauthorization Act of 2017, which directed the agency to issue draft guidance on the factors that will be used in determining whether a Class 1 or Class 2 device type, or subset of such device types, is eligible for review by an accredited person. The guidance is intended to (1) describe factors FDA will use in determining device type eligibility for review by third-party reviewer organizations; (2) outline the agency’s process for the recognition, re-recognition, suspension, and withdrawal of recognition for third-party reviewer organizations; and (3) ensure consistent quality of work among third-party reviewer organizations through the MDUFA 4 commitments authorized under the FDA Reauthorization Act. To view the notice, click here.


Post an instant comment on this report here

 
Any copying or electronic transfer without written permission is strictly prohibited and will result
in termination of service and prosecution under the federal Copyright Act.
To gain permission to copy this article log on to http://www.copyright.com.

FERDIC INCORPORATED - P.O. Box 28, Camp Hill, PA 17001 | Phone: (717)731-1426 fax:(717)731-1427 Email: info@fdaweb.com